| Indication | Drug | Contraindications, side effects and note |
| PCOS (hirsutism, by blocking T to DHT conversion) | |
| Anything (adrenal crisis, chronic adrenal insufficiency) | |
| Hyperthyroidism (more potent, crosses placenta) | |
| T1DM (short acting) | |
| PCOS (hirsutism) | |
| Kidney stones, idiopathic hypercalciuria | |
| Paget's disease, hyperparathyroidism, idiopathic juvenile hypercalcemia, vitamin D toxicosis, osteoporosis | |
| T1DM (long acting) | |
| Osteoporosis, osteomalacia, rickets, hypoparathyroidism | |
| T2DM (by blocking ATP-sensitive K channel) | |
| T2DM (by increasing insulin release) | |
| PCOS (hirsutism, by inhibiting binding of testosterone) | |
| Hyperthyroidism | |
| Hypoglycemia | |
| Hypoaldosteronism, chronic adrenal insufficiency | |
| T1DM and T2DM | |
| PCOS (hirsutism, by inhibiting binding of testosterone) | |
| Precocious puberty | |
| Hyperparathyroidism, hypercalcemia | |
| Obesity (against fat absorption) | |
| | Indication | Drug | Contraindications, side effects and note |
| Hyperthyroidism (less potent, does not cross placenta) | |
| T2DM (by inhibiting carb absorption) | |
| Osteoporosis (for increasing bone mass) | |
| T2DM (by blocking PPAR in adipocytes) | |
| T1DM (long acting) | |
| T1DM (intermediate acting) | |
| T2DM (by blocking ATP-sensitive K channel, weakly) | |
| Paget's disease, osteoporosis, hypercalcemia of malignancy | |
| T2DM (by reducing incretin degradation) | |
| Hypothyroidism | |
| PCOS (for increasing fertility, via blocking estrogen inhibition of hypothalamus) | |
| Myxedema coma, preparing for iodine therapy | |
| Hypothyroidism or hyperthyroidism | |
| Obesity (against appetite) | |
| Obesity (against appetite) | |
| T2DM (by activating AMPPK) | |
| Cortisol suppression tests, psoriasis, eczema | |
| Paget's disease | |
| Hyperaldosteronism (Conn's syndrome) | |
|